| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 01/14/2003 | CA2246758C Peptidomimetic inhibitors of cathepsin d and plasmepsins i and ii |
| 01/14/2003 | CA2023089C Method for the treatment of cardiac and of vascular hypertrophy and hyperplasia |
| 01/09/2003 | WO2003002596A2 Use of dipeptidyl peptidase iv inhibitors as therapeutics for neurological disorders |
| 01/09/2003 | WO2003002595A2 Dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents |
| 01/09/2003 | WO2003002594A1 Hypoglycaemic peptides and methods of use thereof |
| 01/09/2003 | WO2003002593A2 Peptide structures useful for competitive modulation of dipeptidyl peptidase iv catalysis |
| 01/09/2003 | WO2003002545A1 Peptoid compounds |
| 01/09/2003 | WO2002083716A3 Type b botulism toxin inhibitors |
| 01/09/2003 | WO2001098294A3 Vitronectin receptor antagonist pharmaceuticals for use in combination therapy |
| 01/09/2003 | WO2001081369A3 Peptide potentiation of acid-sensory ion channel in pain |
| 01/09/2003 | US20030009050 Useful as a sweetener |
| 01/09/2003 | US20030008829 For therapy and prophylaxis of inflammatory diseases associated with the respiratory tract, such as asthma and allergic rhinitis, immunomediated inflammatory disorders, such as rheumatoid arthritis, conjunctivitis, psoriasis |
| 01/09/2003 | US20030008828 Diagnostic kits; for therapy of viral infection; as assat standard or reagent |
| 01/09/2003 | US20030008047 Stability enhancement of sweeteners using salts containing divalent or trivalent cations |
| 01/09/2003 | CA2452069A1 Hypoglycaemic peptides and methods of use thereof |
| 01/09/2003 | CA2424645A1 New use of dipeptidyl peptidase iv inhibitors |
| 01/09/2003 | CA2419888A1 Peptide structures useful for competitive modulation of dipeptidyl peptidase iv catalysis |
| 01/09/2003 | CA2418543A1 New dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents |
| 01/08/2003 | EP1272622A1 Method for modification of proteins by transglutaminase |
| 01/08/2003 | EP1272516A2 Selective linear peptides with melanocortin-4 receptor (mc4-r) agonist activity |
| 01/08/2003 | EP1272223A1 Therapeutic and diagnostic ligand systems comprising transport molecule binding properties and medicaments containing the same |
| 01/08/2003 | EP1272057A1 Sweeteners, particularly for coffee and tea |
| 01/08/2003 | EP0833839B1 Peptidyl heterocycles useful in the treatment of thrombin related disorders |
| 01/08/2003 | CN1390231A Metal-binding compounds and uses thereof |
| 01/08/2003 | CN1390230A Peptides for treatment of erectile dysfunction |
| 01/08/2003 | CN1390140A Method for linking molecular substances |
| 01/08/2003 | CN1098278C Cinnamic acid derivative |
| 01/08/2003 | CN1098106C Anthracycline conjugates, their preparation and their use as antitumor agents |
| 01/07/2003 | US6503713 Methods for identifying RNA binding compounds |
| 01/07/2003 | CA2143208C Sulfonamide inhibitors of hiv-aspartyl protease |
| 01/07/2003 | CA2076307C Orally-active elastase inhibitors |
| 01/07/2003 | CA2075590C Hydantoin derivatives |
| 01/03/2003 | WO2003000716A2 Preparation and use of amorphous lisinopril |
| 01/03/2003 | WO2003000680A1 Diamine derivatives |
| 01/03/2003 | WO2003000657A1 Diamine derivatives |
| 01/03/2003 | WO2003000198A2 Selective neuronal nitric oxide synthase inhibitors |
| 01/03/2003 | WO2002070545A3 Siderophore analogues as tetra- or hexadentate iron chelators on the basis of amino acids or peptides, method for producing them and the use thereof |
| 01/03/2003 | WO2002008187A9 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 01/02/2003 | US20030004308 Anticoagulants |
| 01/02/2003 | US20030004114 Method of inhibiting fungal growth |
| 01/02/2003 | US20030003461 Truncation selex method |
| 01/02/2003 | US20030003049 Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation |
| 01/02/2003 | EP1271211A2 Optical coupling device with optical waveguide coupled to optical device |
| 01/02/2003 | EP1270577A1 Furoisoquinoline derivatives, process for producing the same and use thereof |
| 01/02/2003 | EP1268544A2 Peptides blocking vascular endothelial growth factor (vegf)-mediated angiogenesis, polynucleotides encoding said peptides and methods of use thereof |
| 01/02/2003 | EP1268527A2 Nucleic acids, proteins, and antibodies |
| 01/02/2003 | EP1268525A2 Macrocyclic ns3-serine protease inhibitors of hepatitis c virus comprising n-cyclic p2 moieties |
| 01/02/2003 | EP1268519A2 Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease |
| 01/02/2003 | EP1268518A1 Insulin potentiating peptides |
| 01/02/2003 | EP1268497A1 Ternary ligand complexes useful as radiopharmaceuticals |
| 01/02/2003 | EP1268434A1 Cyclic lactams as inhibitors of a-beta protein production |
| 01/02/2003 | EP1268433A1 Cyclic lactams as inhibitors of a-beta-protein production |
| 01/02/2003 | EP1268424A1 Method for synthesis of perindopril and its pharmaceutically acceptable salts |
| 01/02/2003 | EP1268414A1 Ceramide derivatives and method of use |
| 01/02/2003 | EP1268000A1 Spiropiperidine derivatives as melanocortin receptor agonists |
| 01/02/2003 | EP1267939A2 Polyglutamic acid-camptothecin conjugates and methods of preparation |
| 01/02/2003 | EP1267906A1 Lactams as inhibitors of a-beta protein production |
| 01/02/2003 | EP1053246B1 Beta-sheet mimetics and methods relating to the use thereof |
| 01/02/2003 | EP1030831A4 Process for the preparation of azacycloalkylalkanoyl pseudotetrapeptides |
| 01/02/2003 | EP1019370B1 Ace-inhibitor nitric salts |
| 01/02/2003 | EP0920445B1 Synthetic peptides and their use in cosmetic or dermopharmaceutical compositions |
| 12/31/2002 | US6500959 Pyrrolidine derivatives and processes for preparing same |
| 12/31/2002 | US6500841 Inhibitors of farnesyl-protein transferase |
| 12/31/2002 | US6500832 Administering enzyme inhibitors as viricides for prophylaxis of viral diseases such as aquired immune deficiency syndrome |
| 12/31/2002 | US6500803 Factor VIIa inhibitors |
| 12/31/2002 | US6500802 Peptidyl-2-amino-1-hydroxyalkanesulfonic acid cysteine protease inhibitors |
| 12/31/2002 | CA2266497C Liquid detergents containing proteolytic enzyme and protease inhibitors |
| 12/27/2002 | WO2002102832A1 Use of fragments of oxytocin for the preparation of a pharmaceutical composition in order to create eustasis |
| 12/27/2002 | WO2002102764A2 Method for producing chiral amino acid derivatives |
| 12/27/2002 | WO2001034631A3 PEPTIDE ANALOGS AND MIMETICS SUITABLE FOR IN VIVO USE IN THE TREATMENT OF DISEASES ASSOCIATED WITH ABNORMAL PROTEIN FOLDING INTO AMYLOID, AMYLOID-LIKE DEPOSITS OR β-SHEET RICH PATHOLOGICAL PRECURSOR THEREOF |
| 12/26/2002 | US20020198386 Lactam-aldehyde compound and process of preparing same |
| 12/26/2002 | US20020198360 Structural models for cytoplasmic domains of transmembrane receptors |
| 12/26/2002 | US20020198156 Asymmetric synthesis of (S,S,R)-(-)-actinonin and its analogs and uses therefor |
| 12/26/2002 | US20020197661 Tryptase substrates and assay for tryptase activity using same |
| 12/26/2002 | US20020197657 Apoptosis-related compounds and their use |
| 12/26/2002 | US20020197602 Nucleic acid sequences and proteins associated with aging |
| 12/26/2002 | US20020197010 Optical transmission device with optical waveguide coupled to optical device |
| 12/25/2002 | CN1387577A Process for producing product contg. antihypertensive tripeptides |
| 12/25/2002 | CN1387564A Lactobacillus helvetius producing antihypertensive di- and tripeptides |
| 12/24/2002 | US6498233 Nucleic acid transfer system |
| 12/19/2002 | WO2002100886A1 Pyrrolidin-2-one derivatives as inhibitors of factor xa |
| 12/19/2002 | WO2002100883A2 Libraries of conformationally constrained peptides, chiral azacrowns, and peptidomimetics and methods of making the same |
| 12/19/2002 | WO2002100845A1 Hv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 12/19/2002 | WO2002100844A2 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 12/19/2002 | WO2002100353A2 Cd10-activated prodrug compounds |
| 12/19/2002 | WO2002100344A2 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
| 12/19/2002 | WO2002100172A1 Administration of agents via the pept-2 transporter |
| 12/19/2002 | WO2002012269A3 Pharmaceutical composition comprising an analgesic peptide |
| 12/19/2002 | US20020193621 Method for preparing highly stable crystals of aspartame derivative |
| 12/19/2002 | US20020193562 Angiotensin converting enzyme (ACE); neutral endopeptidase (NEP); containing a dipeptide derived from an amino acid, or a conformationally restricted dipeptide mimic |
| 12/19/2002 | US20020193312 For therapy of asthma, Alzheimer's disease, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, multiple sclerosis, rheumatoid arthritis, tissue transplantation, tumor metastasis, meningitis, encephalitis, stroke, nephritis |
| 12/19/2002 | US20020193311 Novel cytostatic conjugates with integrin ligands |
| 12/19/2002 | US20020193298 Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 12/19/2002 | US20020192792 Laccase mutants |
| 12/19/2002 | US20020192780 Novel anti-inflammatory peptides |
| 12/19/2002 | CA2450316A1 Cd10-activated prodrug compounds |
| 12/19/2002 | CA2450269A1 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 12/19/2002 | CA2450265A1 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 12/19/2002 | CA2449631A1 Libraries of conformationally constrained peptides, chiral azacrowns, and peptidomimetics and methods of making the same |
| 12/18/2002 | EP1265930A1 Cyclodextrin dimers with spacers having peptide structures for encapsulation of pharmaceutically active substances with potential high side-effects |